Legal & General Group Plc Purchases 220,246 Shares of Xylem Inc. $XYL

Key Points

• Legal & General increased its position in Xylem by 220,246 shares (a 12.2% rise) to 2,029,272 shares, representing about 0.83% of the company and valued at roughly $299.3 million.
• Xylem authorized a $1.50 billion share repurchase (up to 4.8% of outstanding shares), raised its quarterly dividend to $0.43 (annualized $1.72, ~1.4% yield), and reported quarterly results in line with estimates while setting FY2026 EPS guidance of 5.35–5.56.
• Institutional ownership stands at about 87.96%, with large investors like Norges Bank, ABN AMRO, Schroder, Swedbank and Amundi adding or increasing stakes, and analysts maintain a consensus "Moderate Buy" with a $158.08 price target.

Legal & General Group Plc increased its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 12.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,029,272 shares of the industrial products company's stock after purchasing an additional 220,246 shares during the period. Legal & General Group Plc owned 0.83% of Xylem worth $299,318,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Norges Bank purchased a new stake in Xylem in the 2nd quarter worth $338,232,000. ABN AMRO Bank N.V. purchased a new position in shares of Xylem in the second quarter valued at about $208,226,000. Schroder Investment Management Group boosted its stake in shares of Xylem by 2,055.2% in the third quarter. Schroder Investment Management Group now owns 1,192,682 shares of the industrial products company's stock worth $171,687,000 after acquiring an additional 1,137,342 shares during the period. Swedbank AB boosted its stake in shares of Xylem by 19.0% in the third quarter. Swedbank AB now owns 5,197,753 shares of the industrial products company's stock worth $766,669,000 after acquiring an additional 830,821 shares during the period. Finally, Amundi grew its position in shares of Xylem by 17.0% during the second quarter. Amundi now owns 5,714,576 shares of the industrial products company's stock worth $730,717,000 after purchasing an additional 830,337 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.

Xylem Stock Performance

NYSE XYL opened at $122.33 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.62 and a quick ratio of 1.28. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $154.27. The business has a 50 day simple moving average of $134.63 and a two-hundred day simple moving average of $140.20. The stock has a market capitalization of $29.74 billion, a PE ratio of 31.21, a P/E/G ratio of 1.76 and a beta of 1.17.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.42. Xylem had a return on equity of 11.11% and a net margin of 10.59%.The firm's revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.18 EPS. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. On average, research analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem announced that its board has authorized a share repurchase program on Wednesday, February 25th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the industrial products company to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's leadership believes its stock is undervalued.

Xylem Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 24th. Investors of record on Tuesday, February 24th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Tuesday, February 24th. This is a positive change from Xylem's previous quarterly dividend of $0.40. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. Xylem's payout ratio is currently 43.88%.

Analysts Set New Price Targets

Several brokerages recently issued reports on XYL. TD Cowen reissued a "hold" rating on shares of Xylem in a research note on Monday, February 23rd. Citigroup cut their price objective on shares of Xylem from $182.00 to $174.00 and set a "buy" rating for the company in a report on Wednesday, February 11th. William Blair assumed coverage on shares of Xylem in a research report on Monday, January 26th. They set an "outperform" rating on the stock. Wall Street Zen downgraded shares of Xylem from a "buy" rating to a "hold" rating in a report on Saturday, December 27th. Finally, Barclays dropped their target price on shares of Xylem from $166.00 to $156.00 and set an "overweight" rating for the company in a research report on Wednesday, February 11th. Nine research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $158.08.

Xylem Profile

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.